Does RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E Cause Hyperhidrosis? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Hyperhidrosis have been filed in association with RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E. This represents 2.2% of all adverse event reports for RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E.
10
Reports of Hyperhidrosis with RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E
2.2%
of all RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E reports
0
Deaths
2
Hospitalizations
How Dangerous Is Hyperhidrosis From RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E?
Of the 10 reports, 2 (20.0%) required hospitalization.
Is Hyperhidrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E Cause?
Herpes zoster (112)
Pain (93)
Vaccination failure (74)
Rash (64)
Pyrexia (50)
Fatigue (48)
Drug ineffective (44)
Nausea (40)
Pain in extremity (38)
Arthralgia (36)
What Other Drugs Cause Hyperhidrosis?
DULOXETINE (4,101)
ADALIMUMAB (2,745)
SODIUM (2,444)
VENLAFAXINE (1,932)
LEVOTHYROXINE (1,856)
ACETAMINOPHEN (1,578)
ETANERCEPT (1,521)
MORPHINE (1,438)
GABAPENTIN (1,408)
PREGABALIN (1,385)
Which RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E Alternatives Have Lower Hyperhidrosis Risk?
RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E vs REGADENOSON
RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E vs REGORAFENIB
RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E vs REGORAFENIB\REGORAFENIB
RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E vs RELATLIMAB
RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E vs RELPAX